There is a small box on the side of the tube that reads 'Exosome 2%'. It looks like a dose, and in a market where exosomes and salmon-derived PDRN are the ingredients of the moment, it is meant to. Maxclinic's own Korean ingredient panel, however, lists centella callus extracellular vesicles at 100 parts per million and sodium DNA, the PDRN ingredient, at 100 parts per million too. That is 0.01 percent each. The 2 percent refers to the raw material solution, not to the vesicles in the finished cream. It is not a deception exactly, since the brand discloses the real numbers, but it changes what this eye cream should be bought for.
Maxclinic is a Korean brand from around 2017, best known for its oil-to-foam cleansers, and its Exosome PDRN line is its most trend-driven range. A repair ampoule and a lift cream came first, riding the wave of salmon-DNA and exosome products that swept Korean skincare in 2024 and 2025. This eye cream arrived in early 2026 with an 'RX' mark on the tube and a chrome massage tip at the nozzle, a clear bid to look like a clinic treatment.
The good news is that the formula underneath the trend is competent. Glycerin comes second, followed by a light ester, methylpropanediol, caprylic/capric triglyceride and then niacinamide, sixth on the list. For the thin, easily dulled skin around the eyes, niacinamide is a sensible choice: it supports barrier lipids, reduces water loss, and over weeks can soften dullness and uneven tone. Adenosine appears mid-list, ahead of the PDRN and exosomes, and is most likely there at the level Korea requires for a wrinkle-care functional claim; small studies link it to modest smoothing of fine lines. Shea butter, behenyl alcohol, cetyl palmitate, synthetic beeswax and a pair of silicones give the cream its cushion and its silky finish.
The headline actives are another matter. PDRN, or polydeoxyribonucleotide, has genuine clinical data, but almost all of it concerns injected forms used after procedures or for wound healing. Topical sodium DNA at 100 ppm in a cream has no comparable evidence. Plant exosomes are an even younger category, with mostly laboratory data behind them. Then there is a long run of peptides at the very end of the list, palmitoyl pentapeptide-4, copper tripeptide-1, acetyl hexapeptide-8, palmitoyl tripeptide-1 and several others. They add to the firming message, but at those positions their individual contribution is likely small. None of these ingredients is harmful. They are simply not the reason the cream feels good.
What does make it feel good is the texture and the applicator. The bright-white cream glides through the metal tip, which feels cool against the skin and makes it easy to lay a thin line along the orbital bone and pat it in. It absorbs within a minute and leaves a smooth, slightly powdery-silky surface that sits well under concealer without creasing. Aluminium starch octenylsuccinate and polymethylsilsesquioxane are responsible for that soft-focus finish. The cool metal can give a brief reduction in morning puffiness, as any chilled applicator does, though the effect is temporary.
The main drawback is fragrance. The formula contains added perfume and spearmint extract, both of which are hard to justify on the most delicate skin of the face. Most people will not notice any problem, but sensitive eyes, contact lens wearers and anyone prone to eyelid dermatitis may feel a slight tingle or react over time. It is worth patch-testing on the outer corner of one eye before using it all around. The rich esters and emollients also make it unsuitable for strict fungal-acne routines, though that is rarely a concern around the eyes.
Expectations around dark circles need to be realistic too. Niacinamide can gradually brighten dullness, and the moisturising base can make the under-eye area look smoother and less crepey, but circles caused by genetics, hollowing or pigment are unlikely to change much with any cream. The same applies to deep crow's feet; the combination of adenosine and moisturisation softens fine lines, not established wrinkles.
Price sits at around thirty-three dollars on Amazon for 20ml, which is mid-range for an eye cream. A rice-grain amount per eye twice a day makes a tube last about three months, so the monthly cost is reasonable. Maxclinic's heritage is in cleansers, and the brand has no clinical data on this specific product, so the price is best judged on the niacinamide, adenosine and texture rather than on the PDRN and exosome story. On that basis it is fair, if not a bargain.
In a routine, it slots in easily. Apply it after serums and before face cream, morning and night, keeping it to the orbital bone rather than right up to the lash line. It pairs well with a retinoid at night, either as a buffer applied first or on its own around the eyes where a retinoid might be too strong. In the morning it sits comfortably under sunscreen and concealer. Wiping the metal tip after each use stops product drying in the nozzle.
The conclusion is a balanced one. The Maxclinic Exosome PDRN Eye Cream is a well-textured, comfortable eye cream with a sensible backbone of niacinamide and adenosine and a genuinely pleasant applicator. It is not a PDRN or exosome treatment in any meaningful sense, and its fragrance is a misstep for the eye area. For non-sensitive eyes and realistic expectations, it is a nice daily eye cream; for anyone buying it for the trend ingredients, the brand's own label says why that would be a mistake.
